Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 23 May 2000
Vol. 2000, Issue 33, p. tw7
[DOI: 10.1126/scisignal.332000tw7]

EDITORS' CHOICE

Immunology Same Receptor, Different Effects

The anti-inflammatory action of annexin I, a secreted calcium- and phospholipid-binding protein, includes inhibiting neutrophil transmigration from the blood into tissue. Walther et al. report that annexin I acts through the formyl peptide receptor (FPR) on human neutrophils. In contrast, bacterial formyl peptides, the classical FPR ligands, are proinflammatory. When bound to the receptor, annexin I-derived peptides and formyl peptides elicit a similar elevation in intracellular calcium in a G-protein-dependent manner. Competition assays indicate that the two peptides likely bind to different regions of FPR. The authors propose that the two different ligands activate different receptor-initiated signaling cascades that result in opposing inflammatory responses.

Walther, A., Riehemann, K., and Gerke, V. (2000) A novel ligand of the formyl peptide receptor: Annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5: 831-840. [Online Journal]

Citation: Same Receptor, Different Effects. Sci. STKE 2000, tw7 (2000).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882